TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8205595

Group type: EXPERIMENTAL
Intervention: Lansoprazole and amoxicillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lansoprazole alone
Number of subjects: 0
Study: 364059

Group type: EXPERIMENTAL
Intervention: Doxycycline administered before and during the first three postoperative days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31288751

Group type: EXPERIMENTAL
Intervention: Gift certificate (50 EUR)
Number of subjects: 698

Group type: COMPARATOR
Intervention: Lottery (two prizes of 500 EUR and 1000 EUR)
Number of subjects: 698

Group type: COMPARATOR
Intervention: Handwritten name and address
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Printed label
Number of subjects: 698

Group type: COMPARATOR
Intervention: Postal invitation
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: E-mail invitation
Number of subjects: 698
Study: 29389753

Group type: EXPERIMENTAL
Intervention: Computer-assisted TKA
Number of subjects: 282
Study: 26757466

Group type: EXPERIMENTAL
Intervention: Nitinol coils treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 25022821

Group type: EXPERIMENTAL
Intervention: High-output (therapeutic) stimulation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low-output (active control) stimulation
Number of subjects: 41
Study: 22485233

Group type: EXPERIMENTAL
Intervention: Proseal Laryngeal Mask Airway (PLMA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endotracheal Tube (ET)
Number of subjects: 80
Study: 20642548

Group type: EXPERIMENTAL
Intervention: febuxostat 80 mg + hydrochlorothiazide 50 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: febuxostat 80 mg alone
Number of subjects: 36
Study: 17667643

Group type: EXPERIMENTAL
Intervention: Maximal cardiorespiratory fitness (measured during a maximal test on a cycle ergometer)
Number of subjects: 2845
Study: 15832147

Group type: EXPERIMENTAL
Intervention: Soft bandage
Number of subjects: 39

Group type: COMPARATOR
Intervention: Plaster cast
Number of subjects: 39
Study: 12058515

Group type: EXPERIMENTAL
Intervention: Occupational therapy for cognitive-perceptual abilities
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Occupational therapy for motor capacities
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Inhibitory splinting
Number of subjects: 832
Study: 10548709

Group type: EXPERIMENTAL
Intervention: Enlarged port site (group A)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Culdotomy opening (group B)
Number of subjects: 31
Study: 7748586

Group type: EXPERIMENTAL
Intervention: Hospital-based group (capitated fee for all services)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician-based group (fee-for-service for each service)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition program eligibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation program eligibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol counseling program eligibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dementia/depression evaluations eligibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General use of preventive services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encouragement by doctors
Number of subjects: 0
Study: 2263931

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 20
Study: 6449095

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SCH 1000
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 30616086

Group type: EXPERIMENTAL
Intervention: Cancer registrations at one‐year post‐diagnosis
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Cancer registrations at six‐years post‐diagnosis
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Cancer registrations (one‐year post‐diagnosis) & hospital episode statistics combined
Number of subjects: 641
Study: 27503249

Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine curcumin extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard curcumin extract
Number of subjects: 0
Study: 25569524

Group type: EXPERIMENTAL
Intervention: Surgery (decompressive laminectomy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoperative care
Number of subjects: 0
Study: 23770890

Group type: EXPERIMENTAL
Intervention: Moderate cycling exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Common relaxation
Number of subjects: 11
Study: 21087294

Group type: EXPERIMENTAL
Intervention: Immediate non-occlusal loading (restored with a non-occluding temporary crown within 24 hours after implant placement)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional loading (restored according to a two-stage procedure after 3 months)
Number of subjects: 62
Study: 18608144

Group type: EXPERIMENTAL
Intervention: AAC device primed with task specific vocabularies
Number of subjects: 0

Group type: COMPARATOR
Intervention: AAC device not primed with task specific vocabularies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two different emulations of human performance
Number of subjects: 0
Study: 17961903

Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) with adhesive system (SA primer and Photo Bond) under water contamination
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) without adhesive system under water contamination
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) with adhesive system under saliva contamination
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) with adhesive system under dry conditions
Number of subjects: 128

Group type: COMPARATOR
Intervention: Fissure sealant (Teethmate F) under dry conditions
Number of subjects: 128
Study: 15151953

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy followed by surgery (CRT-S)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 101
Study: 12164890

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation during hemodialysis
Number of subjects: 85
Study: 9854466

Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptamine (serotonin) infusion at increasing doses (15 nmol.min-1.kg-1 and 60 nmol.min-1.kg-1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 0
Study: 7824143

Group type: EXPERIMENTAL
Intervention: IQCODE
Number of subjects: 460
Study: 2096043

Group type: EXPERIMENTAL
Intervention: Left hemicolectomy
Number of subjects: 260

Group type: COMPARATOR
Intervention: Segmental colectomy
Number of subjects: 260
Study: 406103

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sodium cromoglycate
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined treatment (betamethasone valerate and sodium cromoglycate)
Number of subjects: 22
Study: 31209607

Group type: EXPERIMENTAL
Intervention: 20-gauge FNB needle
Number of subjects: 88

Group type: COMPARATOR
Intervention: 25-gauge FNB needle
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 30202856

Group type: EXPERIMENTAL
Intervention: Endoscopic Trimodal Imaging (ETMI)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy (CE)
Number of subjects: 210
Study: 26479132

Group type: EXPERIMENTAL
Intervention: Daily monitoring condition (n = 89)
Number of subjects: 176

Group type: COMPARATOR
Intervention: No monitoring condition (n = 87)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Daily report total cigarettes
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Hair nicotine (NIC), hair cotinine (COT), and expired-air carbon monoxide (CO)
Number of subjects: 176
Study: 24731062

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets (SLB; F1000, Leone S.p.A.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional brackets (CB; Avex Mx, OPAL orth.)
Number of subjects: 40
Study: 22531569

Group type: EXPERIMENTAL
Intervention: True TENS on acupoints (bilateral P6, L14; ST36, GB31 ipsilateral to the surgery site)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 68
Study: 20350035

Group type: EXPERIMENTAL
Intervention: High school risk behaviors leading to increased first-semester college risk behaviors (sexual partners, hookups, heavy episodic drinking, heavy drinking contexts)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: College risk behaviors (higher levels of risk taking)
Number of subjects: 469
Study: 17682112

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/d
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/d
Number of subjects: 937

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 937
Study: 15727691

Group type: EXPERIMENTAL
Intervention: High dosage (120 mg/d) of diisopropylamine dichloroacetate
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Low dosage (60 mg/d) of diisopropylamine dichloroacetate
Number of subjects: 123
Study: 12085068

Group type: EXPERIMENTAL
Intervention: Hair Apposition Technique (HAT)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard Suturing
Number of subjects: 189
Study: 9466512

Group type: EXPERIMENTAL
Intervention: Candid 1, a live attenuated Junin virus vaccine
Number of subjects: 6500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6500
Study: 7614525

Group type: EXPERIMENTAL
Intervention: TAA Aqueous 220 micrograms/d
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: TAA Aqueous 110 micrograms/d
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 1974685

Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 0
Study: 365797

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid (CDCA), 200 mg/day for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31991529

Group type: EXPERIMENTAL
Intervention: Chronic stressors (physical, economic, and interpersonal stressor; physical and economic stressor; interpersonal stressor; physical stressor; low stressor)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Coping strategies (cognitive coping, support-seeking, positive problem solving, escape-avoidance)
Number of subjects: 304
Study: 31670004

Group type: EXPERIMENTAL
Intervention: Proactive telemonitored PAP treatment (TG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard PAP treatment (SG)
Number of subjects: 70
Study: 28480505

Group type: EXPERIMENTAL
Intervention: Cardamom supplementation (3 g d-1) for 8 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (identical inert) for 8 weeks
Number of subjects: 80
Study: 26423928

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 2278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2278

Group type: EXPERIMENTAL
Intervention: Combined group (DA and placebo)
Number of subjects: 2278
Study: 22835761

Group type: EXPERIMENTAL
Intervention: Enzyme-inducing antiepileptic drugs (EI-AEDs)
Number of subjects: 35
Study: 21189395

Group type: EXPERIMENTAL
Intervention: AC plus trastuzumab (doxorubicin and cyclophosphamide with trastuzumab)
Number of subjects: 4943

Group type: COMPARATOR
Intervention: AC alone (doxorubicin and cyclophosphamide)
Number of subjects: 4943

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 4943

Group type: EXPERIMENTAL
Intervention: Anthracycline-containing chemotherapy
Number of subjects: 4943
Study: 18548143

Group type: EXPERIMENTAL
Intervention: Lifestyle modifications (dietary sodium restriction, aerobic exercise, weight management, alcohol limitation, diet rich in fruits and vegetables, stress management)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological management (thiazide diuretics, ACE inhibitors, CCBs, ARBs, beta-blockers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (two first-line agents)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACE inhibitors or ARBs for patients with diabetes mellitus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACE inhibitors for patients with proteinuric nondiabetic chronic kidney disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin therapy for selected high-risk patients with hypertension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid therapy
Number of subjects: 0
Study: 16781245

Group type: EXPERIMENTAL
Intervention: 15-minute SHORT cycle bout (LITE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30-minute LONG cycle bout (LITE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 15-minute SHORT cycle bout (MOD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30-minute LONG cycle bout (MOD)
Number of subjects: 45
Study: 14505290

Group type: EXPERIMENTAL
Intervention: Coronary calcium screening with electron beam tomography
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine evaluation using Framingham risk assessment
Number of subjects: 0
Study: 10860407

Group type: EXPERIMENTAL
Intervention: Supportive context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provoking context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hostility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived social support
Number of subjects: 0
Study: 9127392

Group type: EXPERIMENTAL
Intervention: SVC lead position at the brachiocephalic vein
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SVC lead position at mid-RA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SVC lead position at RA-SVC junction
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Best SVC lead position identified in 83% of patients
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Best SVC lead position
Number of subjects: 24
Study: 7941489

Group type: EXPERIMENTAL
Intervention: Board game intervention as a primary prevention teaching strategy
Number of subjects: 23
Study: 3236957

Group type: EXPERIMENTAL
Intervention: Two-week extension and a long period of non-weight bearing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Early mobilisation and partial weight bearing up to the 11th week
Number of subjects: 40
Study: 31916660

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Combination of prolonged exposure and sertraline
Number of subjects: 194

Group type: COMPARATOR
Intervention: No CG
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: CG group
Number of subjects: 194
Study: 30630784

Group type: EXPERIMENTAL
Intervention: Antibiotic impregnated beads
Number of subjects: 72

Group type: COMPARATOR
Intervention: Closed lavage plus drainage
Number of subjects: 72
Study: 25509730

Group type: EXPERIMENTAL
Intervention: Medicinal vesiculation combined with quick cupping at Shenque (CV 8)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Oral administration of loratadine and nasal spray of budesonide
Number of subjects: 82
Study: 22157521

Group type: EXPERIMENTAL
Intervention: T-wave alternans (TWA) measured in lead V(5)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: R-wave heterogeneity (RWH)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: T-wave heterogeneity (TWH)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Matched patients without VT
Number of subjects: 44
Study: 21105792

Group type: EXPERIMENTAL
Intervention: High-protein and low-glycemic-index diet
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: High-protein and high-glycemic-index diet
Number of subjects: 773

Group type: COMPARATOR
Intervention: Low-protein-high-glycemic-index diet
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Low-glycemic-index diet
Number of subjects: 773
Study: 17965119

Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1105
Study: 16115245

Group type: EXPERIMENTAL
Intervention: Dreaming during anaesthesia
Number of subjects: 864
Study: 12867608

Group type: EXPERIMENTAL
Intervention: Fluorouracil-based adjuvant chemotherapy
Number of subjects: 570

Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 570
Study: 10896013

Group type: EXPERIMENTAL
Intervention: Three-month low-intensity supervised exercise (n = 48)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Unsupervised home-based flexibility activities (n = 36)
Number of subjects: 84
Study: 8736270

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy (2.0 IU/m2 per day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 1704985

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Combination of nitrendipine and cilazapril
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 6986758

Group type: COMPARATOR
Intervention: 1000 kcal extra glucose per day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1000 kcal extra fructose per day
Number of subjects: 15
Study: 31638838

Group type: EXPERIMENTAL
Intervention: Whole-grain cereal (WGC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Refined cereal (RC)
Number of subjects: 0
Study: 30701292

Group type: EXPERIMENTAL
Intervention: Local radiotherapy (RT) to the primary tumor and pelvic lymphatics in 44 patients (41%)
Number of subjects: 106

Group type: COMPARATOR
Intervention: No local RT to the primary tumor in 62 patients (59%)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Primary RT to the prostate
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: PSA response ≥50% of baseline obtained 3 weeks after abiraterone therapy
Number of subjects: 106
Study: 26156116

Group type: EXPERIMENTAL
Intervention: Solar-powered oxygen delivery systems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxygen from cylinders
Number of subjects: 0
Study: 23953493

Group type: EXPERIMENTAL
Intervention: Milnacipran (≥100 mg/day)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 151
Study: 21421726

Group type: EXPERIMENTAL
Intervention: SB-773812 56 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SB-773812 100 mg/d
Number of subjects: 30

Group type: COMPARATOR
Intervention: risperidone 6 mg/d
Number of subjects: 30
Study: 19214342

Group type: EXPERIMENTAL
Intervention: 7-8 g oat-bran/d for 12 weeks (fiber group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no oat-bran)
Number of subjects: 30
Study: 17287150

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-BP Monitoring (SBPM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-BP Monitoring plus telephone-based nurse case management (SBPM+NCM)
Number of subjects: 0
Study: 15534128

Group type: EXPERIMENTAL
Intervention: 2% pirenzepine ophthalmic gel
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 11762417

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody therapy
Number of subjects: 0
Study: 9377657

Group type: EXPERIMENTAL
Intervention: Albumin and immunoglobulin levels in cerebrospinal fluid and serum
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CSF/serum albumin ratio
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Serum levels of albumin and immunoglobulins
Number of subjects: 14
Study: 8055291

Group type: EXPERIMENTAL
Intervention: Subconvulsive electrical stimulation during ECT sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Convulsive stimulation during ECT sessions
Number of subjects: 0
Study: 2970853

Group type: EXPERIMENTAL
Intervention: Isradipine (ISRP) 12 mg/day
Number of subjects: 98

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 60 mg/day
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Isradipine (ISRP)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 98
Study: 31718957

Group type: EXPERIMENTAL
Intervention: Mirabegron 50mg
Number of subjects: 568

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 568
Study: 29566659

Group type: EXPERIMENTAL
Intervention: Low-dose, high-frequency (LDHF) training approach
Number of subjects: 403
Study: 28270187

Group type: EXPERIMENTAL
Intervention: HICS treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 24480615

Group type: EXPERIMENTAL
Intervention: Zurich Resource Model (ZRM) training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 24177175

Group type: EXPERIMENTAL
Intervention: Research questionnaire included with FOBt kit
Number of subjects: 47774

Group type: COMPARATOR
Intervention: No research questionnaire included with FOBt kit
Number of subjects: 47774

Group type: EXPERIMENTAL
Intervention: Research questionnaire sent 2-3 days after FOBt kit
Number of subjects: 47774

Group type: COMPARATOR
Intervention: No research questionnaire sent 2-3 days after FOBt kit
Number of subjects: 47774
Study: 21167587

Group type: EXPERIMENTAL
Intervention: Vitadur Alpha discs
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: IPS e.max Ceram discs
Number of subjects: 120
Study: 18716854

Group type: EXPERIMENTAL
Intervention: Modeling intervention (modeling DVD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 16520570

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg of ketamine administered after induction of anesthesia, approximately 5 min prior to surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no ketamine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg of ketamine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 12697866

Group type: EXPERIMENTAL
Intervention: Recombinant human keratinocyte growth factor (KGF) at doses of 60 and 80 microg/kg/d
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 11063766

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally, 3 times a day) during gentamicin therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (gentamicin and placebo)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nifedipine and Placebo
Number of subjects: 32